메뉴 건너뛰기




Volumn 66, Issue 2, 2002, Pages 273-280

Proton pump inhibitors: An update

Author keywords

[No Author keywords available]

Indexed keywords

CEFPODOXIME; CYANOCOBALAMIN; CYTOCHROME P450; DIAZEPAM; ENOXACIN; ESOMEPRAZOLE; GRISEOFULVIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IRON SALT; ITRACONAZOLE; KETOCONAZOLE; LANSOPRAZOLE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PHENYTOIN; PROTON PUMP INHIBITOR; PROTONIX IV; RABEPRAZOLE; SUCRALFATE; WARFARIN;

EID: 0037100685     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (127)

References (24)
  • 7
    • 0030774619 scopus 로고    scopus 로고
    • Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders
    • (1997) Drugs , vol.54 , pp. 473-500
    • Langtry, H.D.1    Wilde, M.I.2
  • 14
    • 0032976315 scopus 로고    scopus 로고
    • Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
    • The Practice Parameters Committee of the American College of Gastroenterology
    • (1999) Am J Gastroenterol , vol.94 , pp. 1434-1442
    • DeVault, K.R.1    Castell, D.O.2
  • 20
    • 0003707380 scopus 로고    scopus 로고
    • Montvale, N.J.: Medical Economics
    • (2000) The Red book
  • 21
    • 0344456481 scopus 로고    scopus 로고
    • Proton pump inhibitor relabeling for cancer risk not warranted
    • T&G- 1-2
    • (1996) FDC Rep , vol.58 , Issue.NOV 11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.